Conjugation with Dihydrolipoic Acid Imparts Caffeic Acid Ester Potent Inhibitory Effect on Dopa Oxidase Activity of Human Tyrosinase

Caffeic acid derivatives represent promising lead compounds in the search for tyrosinase inhibitors to be used in the treatment of skin local hyperpigmentation associated to an overproduction or accumulation of melanin. We recently reported the marked inhibitory activity of a conjugate of caffeic acid with dihydrolipoic acid, 2-S-lipoylcaffeic acid (LCA), on the tyrosine hydroxylase (TH) and dopa oxidase (DO) activities of mushroom tyrosinase. In the present study, we evaluated a more lipophilic derivative, 2-S-lipoyl caffeic acid methyl ester (LCAME), as an inhibitor of tyrosinase from human melanoma cells. Preliminary analysis of the effects of LCAME on mushroom tyrosinase indicated more potent inhibitory effects on either enzyme activities (IC50 = 0.05 ± 0.01 μM for DO and 0.83 ± 0.09 μM for TH) compared with LCA and the reference compound kojic acid. The inhibition of DO of human tyrosinase was effective (Ki = 34.7 ± 1.1 μM) as well, while the action on TH was weaker. Lineweaver–Burk analyses indicated a competitive inhibitor mechanism. LCAME was not substrate of tyrosinase and proved nontoxic at concentrations up to 50 μM. No alteration of basal tyrosinase expression was observed after 24 h treatment of human melanoma cells with the inhibitor, but preliminary evidence suggested LCAME might impair the induction of tyrosinase expression in cells stimulated with α-melanocyte-stimulating hormone. All these data point to this compound as a valuable candidate for further trials toward its use as a skin depigmenting agent. They also highlight the differential effects of tyrosinase inhibitors on the human and mushroom enzymes.

[1]  V. Namasivayam,et al.  Inhibitors of Melanogenesis: An Updated Review. , 2018, Journal of medicinal chemistry.

[2]  K. Röhm,et al.  Structure-Activity Relationships of Thiazolyl Resorcinols, Potent and Selective Inhibitors of Human Tyrosinase , 2018, International journal of molecular sciences.

[3]  F. Solano On the Metal Cofactor in the Tyrosinase Family , 2018, International journal of molecular sciences.

[4]  D. Ruiz-Molina,et al.  Bioinspired Catechol-Based Systems: Chemistry and Applications , 2017, Biomimetics.

[5]  E. Flori,et al.  The α-melanocyte stimulating hormone/peroxisome proliferator activated receptor-γ pathway down-regulates proliferation in melanoma cell lines , 2017, Journal of experimental & clinical cancer research : CR.

[6]  J. García-Borrón,et al.  MC1R signaling. Intracellular partners and pathophysiological implications. , 2017, Biochimica et biophysica acta. Molecular basis of disease.

[7]  A. Napolitano,et al.  2-S-Lipoylcaffeic Acid, a Natural Product-Based Entry to Tyrosinase Inhibition via Catechol Manipulation , 2017, Biomimetics.

[8]  K. Wakamatsu,et al.  Tyrosinase-Catalyzed Oxidation of the Leukoderma-Inducing Agent Raspberry Ketone Produces (E)-4-(3-Oxo-1-butenyl)-1,2-benzoquinone: Implications for Melanocyte Toxicity. , 2017, Chemical research in toxicology.

[9]  V. Namasivayam,et al.  Skin whitening agents: medicinal chemistry perspective of tyrosinase inhibitors , 2017, Journal of enzyme inhibition and medicinal chemistry.

[10]  M. Sugumaran,et al.  Critical Analysis of the Melanogenic Pathway in Insects and Higher Animals , 2016, International journal of molecular sciences.

[11]  M. Sugumaran Reactivities of Quinone Methides versus o-Quinones in Catecholamine Metabolism and Eumelanin Biosynthesis , 2016, International journal of molecular sciences.

[12]  H. Marona,et al.  Melanogenesis Inhibitors: Strategies for Searching for and Evaluation of Active Compounds. , 2016, Current medicinal chemistry.

[13]  S. Shin,et al.  Different effects of five depigmentary compounds, rhododendrol, raspberry ketone, monobenzone, rucinol and AP736 on melanogenesis and viability of human epidermal melanocytes , 2016, Experimental dermatology.

[14]  K. Wakamatsu,et al.  Effects of rhododendrol and its metabolic products on melanocytic cell growth. , 2015, Journal of dermatological science.

[15]  K. Wakamatsu,et al.  A convenient screening method to differentiate phenolic skin whitening tyrosinase inhibitors from leukoderma-inducing phenols. , 2015, Journal of dermatological science.

[16]  K. Wakamatsu,et al.  Tyrosinase‐catalyzed oxidation of rhododendrol produces 2‐methylchromane‐6,7‐dione, the putative ultimate toxic metabolite: implications for melanocyte toxicity , 2014, Pigment cell & melanoma research.

[17]  Z. Abdel‐Malek,et al.  MC1R, the cAMP pathway, and the response to solar UV: extending the horizon beyond pigmentation , 2014, Pigment cell & melanoma research.

[18]  Tamio Suzuki,et al.  Rhododendrol, a depigmentation‐inducing phenolic compound, exerts melanocyte cytotoxicity via a tyrosinase‐dependent mechanism , 2014, Pigment cell & melanoma research.

[19]  V. Hearing,et al.  Melanocytes and their diseases. , 2014, Cold Spring Harbor perspectives in medicine.

[20]  J. García-Borrón,et al.  Differential and competitive regulation of human melanocortin 1 receptor signaling by &bgr;-arrestin isoforms , 2013, Journal of Cell Science.

[21]  M. Picardo,et al.  Mechanisms underlying post-inflammatory hyperpigmentation: lessons from solar lentigo. , 2012, Annales de dermatologie et de venereologie.

[22]  J. Munoz-Munoz,et al.  Unravelling the suicide inactivation of tyrosinase: A discrimination between mechanisms , 2012 .

[23]  Hye-Ryung Choi,et al.  Topical Hypopigmenting Agents for Pigmentary Disorders and Their Mechanisms of Action , 2012, Annals of dermatology.

[24]  A. Slominski,et al.  L‐tyrosine and L‐dihydroxyphenylalanine as hormone‐like regulators of melanocyte functions , 2012, Pigment cell & melanoma research.

[25]  Yoon-Sik Lee,et al.  Dual effects of caffeoyl-amino acidyl-hydroxamic acid as an antioxidant and depigmenting agent. , 2011, Bioorganic & medicinal chemistry letters.

[26]  Z. Abdel‐Malek,et al.  Signaling from the human melanocortin 1 receptor to ERK1 and ERK2 mitogen-activated protein kinases involves transactivation of cKIT. , 2011, Molecular endocrinology.

[27]  V. Hearing,et al.  Update on the regulation of mammalian melanocyte function and skin pigmentation. , 2011, Expert review of dermatology.

[28]  C. Bertolotto,et al.  Fifteen‐year quest for microphthalmia‐associated transcription factor target genes , 2010, Pigment cell & melanoma research.

[29]  N. Smit,et al.  The Hunt for Natural Skin Whitening Agents , 2009, International journal of molecular sciences.

[30]  A. B. Pérez-Oliva,et al.  Mahogunin Ring Finger-1 (MGRN1) E3 Ubiquitin Ligase Inhibits Signaling from Melanocortin Receptor by Competition with Gαs* , 2009, The Journal of Biological Chemistry.

[31]  R. Randall Wickett,et al.  Mechanisms Regulating Skin Pigmentation: The Rise and Fall of Complexion Coloration , 2009, International journal of molecular sciences.

[32]  Te-Sheng Chang,et al.  An Updated Review of Tyrosinase Inhibitors , 2009, International journal of molecular sciences.

[33]  K. Wakamatsu,et al.  Chemistry of Mixed Melanogenesis—Pivotal Roles of Dopaquinone † , 2008, Photochemistry and photobiology.

[34]  V. Hearing,et al.  The Protective Role of Melanin Against UV Damage in Human Skin † , 2008, Photochemistry and photobiology.

[35]  C. Boeriu,et al.  Novel peptides with tyrosinase inhibitory activity , 2007, Peptides.

[36]  Francisco Solano,et al.  Hypopigmenting agents: an updated review on biological, chemical and clinical aspects. , 2006, Pigment cell research.

[37]  T. Okada,et al.  Evidence for covalent lipoyl adduction with dopaquinone following tyrosinase-catalyzed oxidation. , 2006, Biochemical and biophysical research communications.

[38]  D. Tobin,et al.  Melanin pigmentation in mammalian skin and its hormonal regulation. , 2004, Physiological reviews.

[39]  F. Solano,et al.  Conformation-dependent Post-translational Glycosylation of Tyrosinase , 2003, The Journal of Biological Chemistry.

[40]  E. Price,et al.  Modulation of microphthalmia-associated transcription factor gene expression alters skin pigmentation. , 2002, The Journal of investigative dermatology.

[41]  Mei Hong,et al.  Modulation of melanogenesis by aloesin: a competitive inhibitor of tyrosinase. , 2002, Pigment cell research.

[42]  F. Solano,et al.  Identification of active site residues involved in metal cofactor binding and stereospecific substrate recognition in Mammalian tyrosinase. Implications to the catalytic cycle. , 2002, Biochemistry.

[43]  K. Imai,et al.  Synthetic Search for Cosmetic Ingredients: Preparations, Tyrosinase Inhibitory and Antioxidant Activities of Caffeic Amides , 2002 .

[44]  A. Bilska,et al.  [Biologic properties of lipoic acid]. , 2002, Postepy higieny i medycyny doswiadczalnej.

[45]  P. Riley Tyrosinase kinetics: a semi-quantitative model of the mechanism of oxidation of monohydric and dihydric phenolic substrates. , 2000, Journal of theoretical biology.

[46]  Andreina Santagostino,et al.  A User-Friendly Entry to 2-Iodoxybenzoic Acid (IBX) , 1999 .

[47]  C. A. Ramsden,et al.  Melanogenesis-targeted anti-melanoma pro-drug development: effect of side-chain variations on the cytotoxicity of tyrosinase-generated ortho-quinones in a model screening system. , 1997, European journal of cancer.

[48]  C. A. Ramsden,et al.  Tyrosinase-mediated cytotoxicity of 4-substituted phenols: prediction of thiol reactivity of the derived o-quinones , 1995 .

[49]  L. Packer,et al.  alpha-Lipoic acid as a biological antioxidant. , 1995, Free radical biology & medicine.

[50]  C. A. Ramsden,et al.  Tyrosinase‐mediated cytotoxicity of 4‐substituted phenols: Quantitative structure‐thiol-reactivity relationships of the derived o‐quinones , 1994, Anti-cancer drug design.

[51]  K. Urabe,et al.  A new enzymatic function in the melanogenic pathway. The 5,6-dihydroxyindole-2-carboxylic acid oxidase activity of tyrosinase-related protein-1 (TRP1). , 1994, The Journal of biological chemistry.

[52]  A. Winder,et al.  New assays for the tyrosine hydroxylase and dopa oxidase activities of tyrosinase. , 1991, European journal of biochemistry.

[53]  T. Mosmann Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. , 1983, Journal of immunological methods.

[54]  V. Hearing,et al.  Mammalin tyrosinase. Stoichiometry and measurement of reaction products. , 1980, Biochimica et biophysica acta.

[55]  I. C. Gunsalus,et al.  Biosynthesis and Structure of Lipoic Acid Derivatives1 , 1956 .